Outpatient medical abortion is safe and effective through 70 days gestation

被引:32
|
作者
Abbas, Dina [1 ]
Chong, Erica [1 ]
Raymond, Elizabeth G. [1 ]
机构
[1] Gynu Hlth Projects, New York, NY 10010 USA
关键词
UNITED-STATES; MIFEPRISTONE; MISOPROSTOL; TERMINATION; PREGNANCY; REGIMEN;
D O I
10.1016/j.contraception.2015.06.018
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Data show that an outpatient regimen of 200-mg mifepristone followed by a single dose of misoprostol is safe and effective for medical abortion for up to 70 days from last menstrual period (LMP). Yet, many clinics only provide services up to 63 days LMP, and some practice guidelines do not recommend the higher gestational age limit. We review the studies published to date that include women 64 to 70 days LMP and conclude that outpatient medical abortion is safe and effective in this interval and that there are no clinically meaningful differences between outcomes at 57 to 63 days LMP and 64 to 70 days LMP. Updating clinical protocols and revising the Food and Drug administration label for Mifeprex (R) to change the indication for termination of pregnancies through 70 days LMP will give women more choices and expand access to safe abortion services. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:197 / 199
页数:3
相关论文
共 50 条
  • [21] Receiving Abortion Medication Through Mail Was Safe, Effective
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [22] THE EXTENDED GESTATIONAL AGE MEDICAL ABORTION STUDY: THE EFFECTIVENESS OF MEDICAL ABORTION WITH 200 MG MIFEPRISTONE AND 400 MCG SUBLINGUAL MISOPROSTOL AT 57-63 DAYS VS. 64-70 DAYS GESTATION
    Bracken, H.
    Attia, M. B.
    Chelli, H.
    Dabash, R.
    Hajri, S.
    Mundle, S.
    Platais, I
    Posohova, S.
    Raghavan, S.
    Shah, M.
    Swica, Y.
    Tsereteli, T.
    Tsertsvadze, G.
    Winikoff, B.
    Zerarmdini, D.
    CONTRACEPTION, 2011, 84 (03) : 303 - 303
  • [23] Home self-administration of misoprostol for medical abortion up to 56 days' gestation
    Hamoda, H
    Ashok, PW
    Flett, GMM
    Templeton, A
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2005, 31 (03): : 189 - 192
  • [24] Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation
    Saengbanyang, Prakasit
    Wongwananuruk, Thanyarat
    Panichyawat, Nalinee
    Powell, Natchara Sukapatrittikul
    Parkpinyo, Nichamon
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (10):
  • [25] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial
    Bracken, Hillary
    Dabash, Rasha
    Tsertsvadze, George
    Posohova, Svetlana
    Shah, Milind
    Hajri, Selma
    Mundle, Shuchita
    Chelli, Hela
    Zeramdini, Dhouha
    Tsereteli, Tamar
    Platais, Ingrida
    Winikoff, Beverly
    CONTRACEPTION, 2014, 89 (03) : 181 - 186
  • [26] Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City
    Sanhueza Smith, Patricio
    Pena, Melanie
    Dzuba, Ilana G.
    Garcia Martinez, Maria Laura
    Arangure Peraza, Ana Gabriela
    Bousieguez, Manuel
    Shochet, Tara
    Winikoff, Beverly
    REPRODUCTIVE HEALTH MATTERS, 2015, 22 (44) : 75 - 82
  • [28] Outcomes of medical abortion through 63 days in women with twin gestations
    Haves, J. L.
    Achilles, S.
    Reeves, M. F.
    Creinin, M. D.
    CONTRACEPTION, 2008, 78 (02) : 168 - 169
  • [29] Outcomes of medical abortion through 63 days in women with twin gestations
    Hayes, Jennifer L.
    Achilles, Sharon L.
    Creinin, Mitchell D.
    Reeves, Matthew F.
    CONTRACEPTION, 2011, 84 (05) : 505 - 507
  • [30] MEDICAL ABORTION AT OR AFTER 13 WEEKS GESTATION PROVIDED THROUGH TELEMEDICINE SERVICES
    Kapp, N.
    Andersen, K.
    Griffin, R.
    Handayani, A.
    Schellekens, M.
    Gomperts, R.
    CONTRACEPTION, 2020, 102 (04) : 284 - 284